355 related articles for article (PubMed ID: 12535575)
1. Drug efflux transporters in the CNS.
Sun H; Dai H; Shaik N; Elmquist WF
Adv Drug Deliv Rev; 2003 Jan; 55(1):83-105. PubMed ID: 12535575
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier transporters and response to CNS-active drugs.
Urquhart BL; Kim RB
Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
[TBL] [Abstract][Full Text] [Related]
3. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
4. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
5. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
[TBL] [Abstract][Full Text] [Related]
8. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
[TBL] [Abstract][Full Text] [Related]
9. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
de Lange EC
Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
[TBL] [Abstract][Full Text] [Related]
10. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
Akanuma SI
Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.
Farthing CA; Sweet DH
Curr Pharm Des; 2014; 20(10):1472-86. PubMed ID: 23789957
[TBL] [Abstract][Full Text] [Related]
12. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
13. Drug transporters in the central nervous system.
Stieger B; Gao B
Clin Pharmacokinet; 2015 Mar; 54(3):225-42. PubMed ID: 25647629
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-
Betterton RD; Abdullahi W; Williams EI; Lochhead JJ; Brzica H; Stanton J; Reddell E; Ogbonnaya C; Davis TP; Ronaldson PT
Drug Metab Dispos; 2022 Jul; 50(7):942-956. PubMed ID: 35504656
[TBL] [Abstract][Full Text] [Related]
15. Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain.
Sugiyama Y; Kusuhara H; Suzuki H
J Control Release; 1999 Nov; 62(1-2):179-86. PubMed ID: 10518649
[TBL] [Abstract][Full Text] [Related]
16. Neotrofin is transported out of brain by a saturable mechanism: possible involvement of multidrug resistance and monocarboxylic acid transporters.
Yan R; Taylor EM
Drug Metab Dispos; 2002 May; 30(5):513-8. PubMed ID: 11950780
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.
Redzic Z
Fluids Barriers CNS; 2011 Jan; 8(1):3. PubMed ID: 21349151
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
19. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
Wang Q; Zuo Z
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
[TBL] [Abstract][Full Text] [Related]
20. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
